SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001855763-21-000022
Filing Date
2021-09-02
Accepted
2021-09-02 13:04:43
Documents
1
Period of Report
2021-09-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 7867
  Complete submission text file 0001855763-21-000022.txt   9365
Mailing Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7
Business Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7 250-765-6424
Lexaria Bioscience Corp. (Issuer) CIK: 0001348362 (see all company filings)

IRS No.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
SIC: 2834 Pharmaceutical Preparations

Mailing Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7
Business Address
Carle Vanessa (Reporting) CIK: 0001855763 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39874 | Film No.: 211232402